Bristol Myers Squibb Co. (BMY)
61.15
-0.31
(-0.50%)
USD |
NYSE |
Oct 02, 16:00
61.14
-0.01
(-0.02%)
After-Hours: 20:00
Bristol Myers Squibb Price : 61.15 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 60.66 | 61.24 | 60.24 | 61.15 | 9.936M |
| Oct 01, 2026 | 62.20 | 62.61 | 61.25 | 61.46 | 10.77M |
| Sep 30, 2026 | 63.28 | 64.13 | 62.40 | 62.40 | 15.87M |
| Sep 29, 2026 | 63.58 | 63.89 | 61.95 | 62.86 | 15.84M |
| Sep 28, 2026 | 62.77 | 63.93 | 62.30 | 63.88 | 14.02M |
| Sep 25, 2026 | 61.75 | 62.91 | 61.40 | 62.86 | 10.67M |
| Sep 24, 2026 | 61.40 | 61.59 | 60.60 | 61.50 | 14.90M |
| Sep 23, 2026 | 62.31 | 62.65 | 61.08 | 61.15 | 15.84M |
| Sep 22, 2026 | 62.73 | 63.08 | 62.03 | 62.25 | 15.24M |
| Sep 21, 2026 | 63.09 | 63.40 | 62.62 | 62.62 | 6.839M |
| Sep 18, 2026 | 62.71 | 63.06 | 62.19 | 63.06 | 36.85M |
| Sep 17, 2026 | 64.08 | 64.35 | 62.52 | 62.84 | 12.21M |
| Sep 16, 2026 | 64.07 | 64.38 | 63.22 | 63.60 | 9.449M |
| Sep 15, 2026 | 63.94 | 64.13 | 63.15 | 63.73 | 9.996M |
| Sep 14, 2026 | 64.59 | 65.29 | 63.91 | 64.10 | 6.904M |
| Sep 11, 2026 | 64.15 | 64.20 | 63.27 | 63.64 | 7.056M |
| Sep 10, 2026 | 64.92 | 64.92 | 63.73 | 63.75 | 6.496M |
| Sep 09, 2026 | 64.57 | 65.05 | 64.26 | 64.41 | 6.574M |
| Sep 08, 2026 | 65.66 | 65.89 | 64.40 | 64.69 | 9.525M |
| Sep 04, 2026 | 67.24 | 67.72 | 66.58 | 66.82 | 4.825M |
| Sep 03, 2026 | 68.08 | 68.24 | 66.62 | 68.09 | 6.224M |
| Sep 02, 2026 | 66.82 | 67.73 | 66.75 | 67.66 | 7.825M |
| Sep 01, 2026 | 67.58 | 68.04 | 66.64 | 66.92 | 6.934M |
| Aug 31, 2026 | 66.25 | 67.20 | 65.91 | 66.81 | 12.68M |
| Aug 28, 2026 | 66.77 | 66.84 | 66.19 | 66.58 | 5.544M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 256.03 |
| Eli Lilly & Co. | 1142.85 |
| Merck & Co., Inc. | 144.30 |
| Pfizer Inc. | 27.80 |
| AstraZeneca PLC | 156.90 |
Price Related Metrics
| PE Ratio | 13.47 |
| PS Ratio | 2.540 |
| PEG Ratio | 0.162 |
| Price to Book Value | 5.597 |
| Price to Free Cash Flow | 10.92 |
| Earnings Yield | 7.42% |
| Market Cap | 124.93B |
| PEGY Ratio | 0.1543 |
| Operating PE Ratio | 7.852 |
| Normalized PE Ratio | 9.956 |